Five Common Compliance Issues Frequently Cited in FDA Warning Letters for Cosmetic Brands

Entering the U.S. beauty market offers tremendous opportunities for global cosmetic brands, especially with the continued growth of K-Beauty. However, launching a cosmetic product in the United States requires more than creating an innovative formula or attractive packaging.

Many brands face regulatory challenges because they underestimate the importance of FDA compliance requirements.FDA Warning Letters provide valuable insight into the types of compliance issues that can put a brand at risk.

Here are five common FDA compliance issues frequently cited in cosmetic-related Warning Letters.

1. Making Drug-Like Claims on Cosmetic Products

One of the most common issues is using claims that make a cosmetic product appear to be a drug.

Under FDA regulations, cosmetics are intended to cleanse, beautify, promote attractiveness, or alter appearance.

However, claims such as:

• “Treats acne”

• “Heals damaged skin”

• “Regenerates skin cells”

• “Removes wrinkles permanently”

• “Cures eczema”

may change the regulatory classification of a product.

A product marketed with therapeutic claims may be considered an unapproved drug, requiring additional FDA requirements.

Compliance Tip:

Review all product claims carefully — including website descriptions, social media posts, advertisements, and influencer content.

2. Missing or Incorrect Cosmetic Labeling Requirements

Product labeling is one of the first areas FDA reviews during compliance inspections.

Common labeling issues include:

• Incorrect ingredient declarations

• Missing manufacturer or distributor information

• Improper ingredient names

• Misleading product descriptions

• Failure to comply with U.S. labeling requirements

A beautiful package design does not guarantee regulatory compliance.

Before entering the U.S. market, brands should confirm that every label element meets FDA requirements.

3. Failure to Maintain Adequate Safety Documentation

Although cosmetic products generally do not require pre-market FDA approval, companies are responsible for ensuring product safety.

FDA may evaluate whether companies maintain appropriate documentation, including:

• Safety assessments

• Ingredient information

• Manufacturing records

• Product specifications

• Complaint handling procedures

Without proper documentation, brands may struggle to demonstrate product safety.

4. Inadequate Manufacturing and Quality Controls

FDA expects cosmetic companies to manufacture products under conditions that protect consumers.

Common concerns include:

• Poor sanitation practices

• Lack of quality procedures

• Inconsistent manufacturing controls

• Insufficient records

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), cosmetic companies now face increased responsibilities regarding facility registration, product listing, safety substantiation, and adverse event reporting.

5. Failure to Comply With MoCRA Requirements

MoCRA represents the biggest change to U.S. cosmetics regulation in decades.

Cosmetic companies selling products in the U.S. should understand requirements related to:

• Facility registration

• Cosmetic product listing

• Safety substantiation

• Serious adverse event reporting

• Responsible person obligations

Many international brands entering the U.S. market are still unfamiliar with these requirements.

Avoid FDA Compliance Problems Before They Happen

An FDA Warning Letter can impact a brand’s reputation, retailer relationships, and market expansion plans.

For cosmetic brands entering the U.S. market, regulatory preparation should begin before launch — not after receiving an FDA notice.

A successful U.S. beauty launch requires the right balance of:

✔ Innovative products✔ Strong branding✔ FDA compliance strategy

At GlowBridge, we help beauty brands navigate U.S. market entry through Korean OEM/ODM sourcing, regulatory preparation, and launch support.

Planning to launch a K-Beauty product in the U.S.?Contact us to discuss your product strategy and compliance readiness.

Your complete K-beauty bridge to the U.S. From manufacturing to FDA compliance,

we provide a seamless, execution-ready system for your brand's global success.

>>>>Click Here and Start Your Own K-Beauty Products Now

Ready to launch in the U.S.? Contact us today.

CONTACT US

Office: 1-909-229-8249

Email: hello@theglowbridge.com